Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 1,832 | 1,219 | 1,090 | 1,243 | 1,149 |
| Cost of Goods | 1,279 | 1,070 | 1,050 | 972 | 1,086 |
| Gross Profit | 552 | 149 | 30 | 271 | 63 |
| Operating Expenses | 2,565 | 2,528 | 2,020 | 2,953 | 2,382 |
| Operating Income | -1,734 | -2,309 | -1,930 | -1,710 | -2,234 |
| Interest Expense | 389 | 1,294 | 1,450 | 1,312 | 1,083 |
| Other Income | -7,019 | 5,300 | -660 | 3,334 | 1,456 |
| Pre-tax Income | -9,142 | 1,697 | -4,040 | 312 | -1,861 |
| Income Tax | N/A | -664 | 0 | N/A | N/A |
| Net Income Continuous | -9,142 | 2,360 | -4,040 | 312 | -1,861 |
| Net Income | $-9,142 | $2,360 | $-4,040 | $312 | $-1,861 |
| EPS Basic Total Ops | -343.84 | 262.76 | -451.95 | 34.53 | -207.21 |
| EPS Basic Continuous Ops | -344.38 | 262.53 | -451.88 | 34.76 | -207.52 |
| EPS Diluted Total Ops | -343.84 | -327.33 | -623.12 | -334.83 | -348.35 |
| EPS Diluted Continuous Ops | -344.38 | 262.53 | -470.32 | 34.50 | -195.38 |
| EBITDA(a) | $-1,452 | $-1,820 | $-1,381 | $-1,208 | $-1,836 |